Public procurement notice: Contract Award Notice
Published: 2022-01-21
Buyer: AZIENDA SANITARIA LOCALE BENEVENTO
Country: IT
Contract type: Services
Procedure: Open procedure
CPV classification: 32441300 | 33195000 | 48814400 | 72212180 | 73120000
Award criteria: The most economic tender
EU fund: Horizon Europe

Technical requirements: Pre–commercial procurement (PCP) to buy R&D (research and development) services to developing digital solutions supporting continuum of care for frailty prevention in old adults - eCare
The procurement aims to deliver disruptive digital solutions for the prevention and comprehensive management of frailty to encourage independent living, wellbeing and to relieve health and care services budget pressure, throughout the implementation of a Pre-Commercial Procurement scheme. Solutions should improve outcomes for frailty in old adults entailing the physical and the psychosocial factors. The target group are the pre-frail/frail old adults with emphasis on those that feel lonely and/or isolated.  The procurers will procure the development, testing and implementation of digital tools/services and communication concepts to facilitate the transition to integrated care models across health and social services and country-specific cross-institutional set-ups.
The procurement will take the form of a pre-commercial procurement (PCP) under which R&D service contracts will be awarded to a number of R&D providers in parallel in a phased approach. Each selected operator will be awarded a framework agreement that covers 3 R&D phases (described below). After each phase, intermediate evaluations will be carried out to progressively select the best of the competing solutions. The contractors with the best-value-for-money solutions will be offered a specific contract for the next phase.
This phase is a feasibility study of the selected technologies and proposals, which aims to verify the technical, economic and organizational feasibility of each company’s offer. The expected output from participating companies is a report describing the results of the feasibility study. .
The total budget for the R&D contracts in this phase is 321,311.475 € (excluding VAT) and the maximum budget per R&D contract is 40,169.934 € (excluded VAT). Should there is any leftover from this phase it will be transferred to the next one. From this sum at least 8 contracts will be awarded. This phase will last for 5.5 months.
The purpose of this phase is to develop the most promising ideas, shown in Phase A, into well-defined prototypes. The selection process for Phase B is based on the Phase A report and an application process, which will outline the company’s plans for Phase B.
Selected companies will each develop a prototype based on the results of their feasibility study. The aim is to verify to what extent the prototype’s main features meet the functional and performance requirements set in the challenge. Participating companies are expected to deliver a prototype specification and lab demonstration, as well as a plan for original development of a limited volume of first solutions and field-testing, and an updated cost/benefits evaluation including a preliminary business plan.
It is expected that the combined budget for this phase will be 1,606,577.377 € (excluding VAT) and the maximum budget per R&D contract will be 401,639.344 €. Should there is any leftover from this phase it will be transferred to the next one. At least 4 projects will be selected for Phase B. This phase will last 10 months.
This phase aims to verify and compare the full feature set and performance of different solutions in real-life operational conditions of the targeted public service. Expected output from participating companies includes field testing, field test specification, specification of the final solution, other related technical documentation and an updated cost/benefit evaluation.
. It is expected that the combined budget for this phase will be 1,285,245.804 € (excluding VAT) and the maximum budget per R&D contract will be 642,622.950 €. 2 projects will be selected for this phase. This phase will last 12 months.
All the solutions in Phase C will be tested in all the sites to ensure that a comparison can be made of performance both across sites and across solutions. Each procurer will identify a sample population to implement the proof of concept of the final awarded contracts.Testing is expected to take place in:
The phases of the procurement is started in 20/12/2021 and end in 30/06/2024.The PCP challenge, requirements, conditions and awarded criteria will be established in the tender documents.
The selected operators will retain ownership of the intellectual property rights (IPRs) that they generate during the PCP and will be able to use them to exploit the full market potential of the developed solutions. The procurers will enjoy royalty-free access rights to use the R&D results for their own use. The procurers will also enjoy the right to grant or to require participating R&D providers to grant non-exclusive lic
This procurement receives funding from the European Union’s Horizon 2020 Research and Innovation Programme, under grant agreement No 856960 — eCARE. Seehttps://ecare-pcp.eu/The EU has given a grant for this procurement, but is not participating as a contracting authority in the procurement.
This procurement is exempted from the WTO Government Procurement Agreement (GPA), the EU public procurement directives and the national laws that implement them. This is because it concerns the procurement of R&D services where the benefits do not accrue exclusively to the contracting authority for its use in the conduct of its own affairs.


Winner: Bilişim Sağlık Eğitim Dış Ticaret ve San. Ltd.
Number of bids: 19